IRIS Accounts Production v22.2.0.402 SC236596 director 1.1.21 31.12.21 31.12.21 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureSC2365962020-12-31SC2365962021-12-31SC2365962021-01-012021-12-31SC2365962019-12-31SC2365962020-01-012020-12-31SC2365962020-12-31SC236596ns16:Scotland2021-01-012021-12-31SC236596ns15:PoundSterling2021-01-012021-12-31SC236596ns11:Director12021-01-012021-12-31SC236596ns11:PrivateLimitedCompanyLtd2021-01-012021-12-31SC236596ns11:SmallEntities2021-01-012021-12-31SC236596ns11:AuditExempt-NoAccountantsReport2021-01-012021-12-31SC236596ns11:SmallCompaniesRegimeForDirectorsReport2021-01-012021-12-31SC236596ns11:SmallCompaniesRegimeForAccounts2021-01-012021-12-31SC236596ns11:FullAccounts2021-01-012021-12-31SC23659612021-01-012021-12-31SC236596ns11:RegisteredOffice2021-01-012021-12-31SC236596ns6:CurrentFinancialInstruments2021-12-31SC236596ns6:CurrentFinancialInstruments2020-12-31SC236596ns6:ShareCapital2021-12-31SC236596ns6:ShareCapital2020-12-31SC236596ns6:RetainedEarningsAccumulatedLosses2021-12-31SC236596ns6:RetainedEarningsAccumulatedLosses2020-12-31SC236596ns6:NetGoodwill2021-01-012021-12-31SC236596ns6:PlantMachinery2021-01-012021-12-31SC236596ns6:NetGoodwill2020-12-31SC236596ns6:NetGoodwill2021-12-31SC236596ns6:NetGoodwill2020-12-31SC236596ns6:PlantMachinery2020-12-31SC236596ns6:PlantMachinery2021-12-31SC236596ns6:PlantMachinery2020-12-31SC236596ns6:WithinOneYearns6:CurrentFinancialInstruments2021-12-31SC236596ns6:WithinOneYearns6:CurrentFinancialInstruments2020-12-31
REGISTERED NUMBER: SC236596 (Scotland)













FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2021

FOR

KELLOCK PHARMACY LIMITED

KELLOCK PHARMACY LIMITED (REGISTERED NUMBER: SC236596)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2021










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


KELLOCK PHARMACY LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2021







DIRECTOR: D Kellock





REGISTERED OFFICE: 1 Coo Lane
Eaglesham
GLASGOW
G76 0JP





REGISTERED NUMBER: SC236596 (Scotland)





ACCOUNTANTS: Bannerman Johnstone Maclay
213 St Vincent Street
Glasgow
G2 5QY

KELLOCK PHARMACY LIMITED (REGISTERED NUMBER: SC236596)

BALANCE SHEET
31 DECEMBER 2021

2021 2020
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 32,500 65,000
Tangible assets 5 213,374 12,587
245,874 77,587

CURRENT ASSETS
Stocks 74,751 61,751
Debtors 6 58,024 34,558
Cash at bank and in hand 379,089 447,182
511,864 543,491
CREDITORS
Amounts falling due within one year 7 255,709 227,304
NET CURRENT ASSETS 256,155 316,187
TOTAL ASSETS LESS CURRENT
LIABILITIES

502,029

393,774

PROVISIONS FOR LIABILITIES 40,382 -
NET ASSETS 461,647 393,774

CAPITAL AND RESERVES
Called up share capital 2 2
Retained earnings 461,645 393,772
SHAREHOLDERS' FUNDS 461,647 393,774

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2021.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2021 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

KELLOCK PHARMACY LIMITED (REGISTERED NUMBER: SC236596)

BALANCE SHEET - continued
31 DECEMBER 2021


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 7 September 2022 and were signed by:





D Kellock - Director


KELLOCK PHARMACY LIMITED (REGISTERED NUMBER: SC236596)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2021


1. STATUTORY INFORMATION

Kellock Pharmacy Limited is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2003, is being amortised evenly over its estimated useful life of twenty years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on cost and 10% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

KELLOCK PHARMACY LIMITED (REGISTERED NUMBER: SC236596)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2021


2. ACCOUNTING POLICIES - continued

Financial instruments
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include certain debtors and cash and bank balances, are initially measured at transaction price including transactions costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities
Basic financial liabilities, including certain creditors, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 9 (2020 - 9 ) .

KELLOCK PHARMACY LIMITED (REGISTERED NUMBER: SC236596)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2021


4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 January 2021
and 31 December 2021 650,000
AMORTISATION
At 1 January 2021 585,000
Charge for year 32,500
At 31 December 2021 617,500
NET BOOK VALUE
At 31 December 2021 32,500
At 31 December 2020 65,000

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 January 2021 75,658
Additions 205,874
At 31 December 2021 281,532
DEPRECIATION
At 1 January 2021 63,071
Charge for year 5,087
At 31 December 2021 68,158
NET BOOK VALUE
At 31 December 2021 213,374
At 31 December 2020 12,587

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2021 2020
£    £   
Trade debtors 43,484 17,562
Amounts owed by related undertakings 81 181
Other debtors 14,459 16,815
58,024 34,558

KELLOCK PHARMACY LIMITED (REGISTERED NUMBER: SC236596)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2021


7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2021 2020
£    £   
Trade creditors 231,625 138,135
Taxation and social security 5,216 39,086
Other creditors 18,868 50,083
255,709 227,304

8. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is Domkell Limited.